inclusion criteria: * evidence of moderate covid-19, diagnosed standard rt-pcr assay or equivalent testing * willing and able to comply with study procedures and follow-up visits * subject or family member/caregiver must have provided written informed consent which includes signing the institutional review board approved consent form prior to participating in any study related activity. however, if obtaining written informed consent is not possible, other procedures as provided in the march 27th, 2020 fda guidance on conduct of clinical trials of medical products during covid-19 pandemic, question 10, may be used.

inclusion criteria: * evidence of moderate covid-19, diagnosed standard rt-pcr assay or equivalent testing * willing and able to comply with study procedures and follow-up visits * subject or family member/caregiver must have provided written informed consent which includes signing the institutional review board approved consent form prior to participating in any study related activity. however, if obtaining written informed consent is not possible, other procedures as provided in the march 27th, 2020 fda guidance on conduct of clinical trials of medical products during covid-19 pandemic, question 10, may be used.

inclusion criteria: - evidence of moderate covid-19, diagnosed standard rt-pcr assay or equivalent testing - willing and able to comply with study procedures and follow-up visits - subject or family member/caregiver must have provided written informed consent which includes signing the institutional review board approved consent form prior to participating in any study related activity. however, if obtaining written informed consent is not possible, other procedures as provided in the march 27th, 2020 fda guidance on conduct of clinical trials of medical products during covid-19 pandemic, question 10, may be used.

inclusion criteria: - evidence of moderate covid-19, diagnosed standard rt-pcr assay or equivalent testing - willing and able to comply with study procedures and follow-up visits - subject or family member/caregiver must have provided written informed consent which includes signing the institutional review board approved consent form prior to participating in any study related activity. however, if obtaining written informed consent is not possible, other procedures as provided in the march 27th, 2020 fda guidance on conduct of clinical trials of medical products during covid-19 pandemic, question 10, may be used.